We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Actividentity Corp (MM) | NASDAQ:ACTI | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3.24 | 0 | 01:00:00 |
Second quarter in brief
Events after the end of the period
Financial summary
SEK M | Apr-Jun | Jan-Jun | Full year | ||||
2018 | 2017 | 2018 | 2017 | 2017 | |||
Net sales | 5.7 | 5.1 | 10.5 | 9.8 | 20.2 | ||
Operating loss | -7.3 | -23.1 | -15.9 | -37.7 | -102.5 | ||
Loss after tax | -9.1 | -24.4 | -19.3 | -40.2 | -108.8 | ||
Earnings per share (SEK) | -0.07 | -0.20 | -0.15 | -0.33 | -0.89 | ||
Cash and cash equivalents (at close of period) | 45.6 | 47.7 | 25.2 |
For further information, please contact:
Helén Tuvesson, CEO Tel: +46 (0)46 19 21 56 Hans Kolam, CFO Tel: +46 (0)46 19 20 44 | Active Biotech AB (Corp. Reg. No. 556223-9227) Box 724, SE-220 07 Lund Tel: +46 (0)46 19 20 00 |
The report is also available at www.activebiotech.com.
1 Year Actividentity Corp (MM) Chart |
1 Month Actividentity Corp (MM) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions